Global Medical Elastomers Market was valued at US $ 5.55 billion in 2017 and is expected to reach US $ 9.97 billion by 2026, at a CAGR of 7.6% over a forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful information, facts, historical data, industry validated market data, and projections with a set of suitable assumptions and methodologies.

Elastomers are generally thermosetting but can also be thermoplastic. The long polymer chains crosslink during curing, i.e. vulcanization. The effects of temperature are also present in the demonstrated elasticity of a polymer. Elastomers which have cooled to a glassy or crystalline phase will have fewer mobile chains, and therefore less elasticity, than those handled at temperatures above the glass transition temperature of the polymer.

Click here for a sample Premium @ report

Recent trends in the healthcare industry have paved the way for revolutionary innovations in polymer technology. Medical device manufacturers are increasingly turning to thermoplastic elastomers for applications that require rubber-like flexibility or elasticity, and they are turning to Teknor Apex to provide high quality, regulatory and compliant TPEs. having proven themselves.

Based on type, the thermoplastic segment of the medical elastomers market is expected to grow at the highest CAGR between 2017 and 2026. Thermoplastic elastomers are considered a replacement for PVC in applications where phthalate-free or plasticizer-free materials are desired. Globally, intravenous therapy producers are among the first in the medical device industry to switch from PVC materials to TPE materials. TPEs are also replacing thermosetting rubbers (such as silicone, polyisoprene, and butyl rubber) used in elastomeric medical applications, such as septa, caps, and syringe plungers.

You can purchase this report from here @

On the basis of application, the medical tubing segment accounted for the largest share of the medical elastomers market in 2017. The demand for application-based elastomers is increasing for medical tubing, as it does not contain harmful latex. , PVC or bisphenol A. In addition, they are easy to sterilize, recyclable and flexible, and therefore find wide application in types used in the healthcare industry, such as medical bags, catheters and gloves .

The Asia-Pacific region is expected to dominate the medical elastomers market during the forecast period. The growth of the APAC medical elastomers market is attributed to the growing population of the region and the increase in healthcare expenditure of various countries, such as India, Indonesia and China. In addition, increased private and public sector investment to improve health infrastructure in countries is also expected to create demand for medical devices, thus fueling the growth of medical elastomers market in the region.

The report covers global and regional level estimation and analysis of the Medical Elastomers market. The impact of various market factors such as drivers, restraints and opportunities, key challenges of SWOT analysis and technology forecast are also illustrated in the report. The Medical Elastomers Market report covers an in-depth study of the global and regional market and market attractiveness analysis, wherein the application, type, and regional segments are compared on the basis of their growth rate, their general attractiveness and the size of the market.

Scope of the Global Medical Elastomers Market:

Global Medical Elastomers Market, By Type:

Global Medical Elastomers Market, By Application:
Medical tubes
Medical bags

Global Medical Elastomers Market, By Region:
North America
Middle East & Africa
Asia Pacific
South America’

Request for report discounts @

Key players operating in the global medical elastomers market:
Celanese Company
Dow DuPont Inc.
Eastman Chemical Company
Kuraray Co. Ltd.
Mitsubishi Chemical Corporation
Momentive Performance Materials Inc.
Polyone Company
Royal DSM
RTP Company
Solvay SA
Teknor Apex
Trelleborg AB.
Suzhou Hongshuo
Koninklijke DSM NV

Source link